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Abstract
Background: Vertebrate heterochromatin contains a non-allelic variant of the histone H2A called macroH2A1,
which has the characteristic of being three times the size of the canonical H2A. The macroH2A1 C-terminal
extension can recruit onto chromatin the poly-ADP-ribose polymerase (PARP)1, which is crucial for DNA repair. This
led to the speculation that macroH2A1 could be essential for genome surveillance; however, no experimental
evidence supported this hypothesis. Because macroH2A1 has been found to be enriched on the inactive
X-chromosome in females, it is thought to play a role in sex chromosome dosage compensation through its ability
to regulate gene expression. However, more genetic data are needed to further understand the function of
macroH2A1 in mammals.
Results: Deletion of the murine gene H2afy, which encodes for macroH2A1, resulted in lipid accumulation in liver.
Hepatic steatosis caused by H2afy disruption occurred specifically in homozygous mutant females. The metabolic
disorder constantly affected half of the number of homozygote females. Given the mixed genetic background of
the mutants, an unreported genetic modifier is likely to influence the penetrance of the phenotype. In addition,
the X-linked thyroxine-binding globulin (Tbg) gene was specifically upregulated in steatotic livers. Chromatin
immunoprecitation indicated that macroH2A1 is enriched at the Tbg promoter in wild-type female animals,
indicating that increased Tbg expression in H2afy null mutants is likely to be a direct consequence of the absence
of macroH2A1. Furthermore, male mice, which are not prone to the metabolic disorder, had a reduced level of
macroH2A1 incorporated into the Tbg promoter.
Conclusions: Because TBG is the main carrier of the thyroid hormone T4, which regulates energy metabolism,
we propose that overexpression of TBG is responsible for the fat accumulation observed in H2afy-deficient liver.
Moreover, our results suggest that the sexual dimorphism of the steatotic phenotype is probably due to the
different incorporation of macroH2A1 in males and females. In combination with previous studies, our data
demonstrate a role for macroH2A1 in regulating homeostasis in a sex-dependent manner, subject to genetic
background.
Background
The histone variant macroH2A1 has the ability to sub-
stitute for H2A within the nucleosome and to establish
chromatin domains with specific properties, due to its
C-terminal non-histone macrodomain [1]. Incorporation
of macroH2A1 results in the addition of a C-terminal
domain of 25 kDa to a histone fold motif, and thus con-
stitutes the largest known nucleosome modification [1].
MacroH2A1 dynamic recruitment onto the inactive
X-chromosome (Xi) upon inactivation in female mam-
mals indicates a possible function in sex-chromosome
dosage compensation [2-5]. However, quantities of
macroH2A are similar in males and females, suggesting
that a role in X inactivation is not the sole function of
this variant [6].
The presence of macroH2A1 at promoter regions was
shown to inhibit gene expression by in vitro transcrip-
tion analysis of reconstituted nucleosomes containing
macroH2A1 [7-9]. However, knockdown studies per-
formed in cultured cells demonstrated that macroH2A1
is required for both transcriptional silencing [10] and
induction [11,12]. This dual role of macroH2A1 in
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which showed that 12% of the genes enriched in
macroH2A1 escape silencing [13]. Furthermore, the
same study showed that a subset of genes is downregu-
lated upon macroH2A1 knockdown, indicating that
macroH2A1 could act as a positive regulator of tran-
scription at some loci [13].
In vivo, the presence of macroH2A1 is essential for
the silencing of a class of endogenous (non-ecotropic)
murine leukaemia viruses [14]. In addition, macroH2A1
plays a function in NAD
+ catabolism through its role in
the two main pathways of NAD
+ consumption. First,
macroH2A1 binds to poly-ADP polymerase (PARP)-1
and inhibits its enzymatic activity [12,15,16]. PARP-1 is
a nuclear enzyme that catalyzes the cleavage of NAD
+
into ADP-ribose and nicotinamide, and the subsequent
transfer of ADP-ribose units to target proteins [17].
PARP-1 is implicated in chromatin structure modula-
tion, transcription regulation and double-strand break
(DSB) DNA repair [17]. Secondly, macroH2A1 binds the
metabolite O-acetyl-ADP-ribose produced by the NAD
+
dependent histone deacetylase Sirt1 [18]. Although all
these recent findings provide biochemical evidence indi-
cating that macroH2A1 plays a role in NAD
+ catabo-
lism, genetic evidence is needed to identify its function
in energy metabolism in mammals.
In this study, we generated loss-of-function animals
through targeted disruption of H2afy,t h eg e n et h a t
encodes macroH2A1. Mice that lacked macroH2A1 dis-
played no obvious visible phenotype and no increased
sensitivity to ionizing radiation, which excludes an
essential function for macroH2A1 in genome surveil-
lance. However, we found that macroH2A1-deficient
females exhibit liver lipid homeostasis defects that lead
to hepatic steatosis. Interestingly, lipid accumulation in
the liver was specific to females. We provide evidence of
reactivation of the X-linked thyroxine-binding globulin
(Tbg) gene specifically in steatotic livers. We also
demonstrate that the histone variant macroH2A1 is spe-
cifically enriched in nucleosomes that occupy the Tbg
promoter in female hepatocytes, indicating that Tbg
overexpression is a direct consequence of H2afy
disruption.
Results
Targeting the mouse H2afy locus
We generated an H2afy null-mutant mouse strain by
homologous recombination in ES cells. Our strategy
resulted in the complete disruption of exon 2, which
encodes the translation start codon and approximately
half of the histone domain (Figure 1a, b).
Mating of heterozygous animals resulted in offspring
of all genotypes at the mendelian ratio (95 heterozygous,
68 wild types and 48 homozygous) and the overall sex
ratio was close to 1:1. Mice homozygous for the H2afy
mutation were viable, and survived to adulthood without
discernible morphological abnormalities. Both male and
female H2afy
-/- mutants were fertile and produced litter
sizes comparable with the wild type.
Absence of the macroH2A1 protein in tissues was
confirmed in homozygous mice by immunoblotting
using a specific antibody (Figure 1c). To determine
whether compensation might be involved, the expres-
sion level of macroH2A2 (H2afy2) was examined in dif-
ferent tissues. MacroH2A2, which is 80% identical to
macroH2A1, is encoded by a separate gene located on
chromosome 10 [19,20]. Little is known about this sec-
ond macroH2A subtype, but it was recently shown to be
crucial for zebrafish (Danio rerio) embryogenesis [21]. In
contrast to many human cells and mouse, zebrafish
embryos predominantly express H2afy2, whereas H2afy
was not detectable [21].
No overexpression of H2afy2 was observed in the
absence of macroH2A1 (Figure 1c). Therefore, it is unli-
kely that the absence of a phenotype in H2afy-deficient
animals is the result of a functional compensation by
H2afy2.
MacroH2A1 is not essential for DNA damage repair
Because macroH2A1 interacts with PARP-1, which is
essential for early DNA damage recognition and base
excision repair by sensing DNA nicks [17], it has been
proposed that macroH2A1 could play a role in the pro-
cess of DNA repair through its ability to recruit PARP1
onto chromatin [12,16].
To determine whether macroH2A1 is essential for
DSB repair in vivo, we tested the sensitivity of H2afy-
deficient mice to whole-body ionizing sublethal irradia-
tion. Mice lacking macroH2A1 did not show any
increased sensitivity to gamma radiation compared with
control littermates (Figure 2). Histological sections
through the duodenum did not show any difference in
the size of villi between mutant and control mice (data
not shown), indicating normal ionizing radiation-
induced cell renewal. We conclude that macroH2A1 is
not required for accurate DNA break repair in vivo.
Absence of macroH2A1 induces hepatic steatosis
in females
Histological examination of all major organs, including
brain, kidney, spleen, heart, visceral fat and reproductive
o r g a n s ,s h o w e dn od i f f e r e nces between macroH2A1-
deficient mice and control littermates up to 12 weeks of
age. However, analysis of liver from H2afy
-/- females
revealed signs of hepatic steatosis (Figure 3, Table 1). Of
17 mutant females, nine displayed periportal hepatocel-
lular macrovacuolation (Figure 3a, b), a phenotype that
was not observed in any mutant male or in wild-type
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Page 2 of 13Figure 1 H2afy gene-targeting strategy and genotyping of cells and mice. (a) Schematic diagrams of the H2afy locus, the targeting vector
and the mutant H2afy alleles are shown. The exons are numbered. The targeting construct containing a neomycin (Neo) cassette flanked by
two loxP sites (triangles) was inserted in place of exon 2, resulting in the deletion of the first coding exon, which encodes amino acids 1 to 57.
The targeted locus lacks the translation initiation codon and half of the sequence coding for the histone region, and should therefore function
as a null allele. The first 18 nucleotides (non-coding) of exon 2 were not modified by the targeting in order to maintain the correct splicing of
the first exon to the second. This mutation affects both splicing isoforms macroH2A1.1 and macroH2A1.2, because they are generated by
alternative splicing of exon 6. Probes used for the Southern blot studies and relevant restriction fragments predicted by digestion of the
recombinant are shown. The sizes of the diagnostic fragments for the wild-type (WT) and H2afy mutant alleles are indicated. (b) Southern blot
analysis of recombinant embryonic stem cells (digested with EcoRI). The blots were hybridized with the probes shown in (a). (c)
Immunodetection of macroH2A1 and macroH2A2 in H2afy
-/- and wild-type mice. Nuclear extracts were prepared from various tissues. The
protein macroH2A1 was undetectable in the mutant tissue, proving that the targeted mice were null mutants. There was no overexpression of
macroH2A2, which was detected only in brain and embryo (data not shown). H2B shows equal protein loading between all lanes. The
additional fast migrating bands seen in testis are probably caused by the crossreactivity of the anti-H2B antibody with the testis-specific variant
of histone H2B.
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tions with oil red O that this vacuolation was the result
of abnormal triglyceride accumulation in liver (Figure
3c, d). Hence, we conclude that the absence of
macroH2A1 induces steatosis.
Reactivation of non-ecotropic MLV is not the cause of
hepatic steatosis
Incorporation of macroH2A1 in chromatin has been
shown to be required for the silencing of the endogen-
ous retrovirus murine leukemia virus (MLV) [14]. To
explore a possible correlation between MLV overexpres-
sion and hepatic steatosis, we assessed MLV env tran-
scription in H2afy
-/- female steatotic livers compared
with H2afy
-/- female healthy livers and wild-type female
livers (Figure 4a).
Transcription of MLV elements was not detected
above background level in three of four wild-type sam-
ples. Surprisingly, an MLV transcript was detected in
one wild-type sample (Figure 4a), showing that MLV
can also be transcribed in the presence of macroH2A1;
this may reflect the segregation of a gene unlinked to
H2afy that regulates MLV expression. Quantification of
the northern-blot data confirmed that MLV silencing is
lost in the absence of macroH2A1, as previously
reported [14]. MLV expression level, normalized to
GAPDH, was upregulated by 2.3-fold in H2afy
-/-
mutants (Figure 4b), but no significant difference was
observed between healthy mutant livers and steatotic
livers (Figure 4b). We therefore exclude a relationship
between hepatic steatosis and MLV overexpression in
the absence of macroH2A1.
Hepatic accumulation of lipids is correlated with
upregulation of the X-linked Tbg gene
A major cause of hepatic steatosis is the increased fatty
acid flux to the liver caused by a high level of free fatty
acids in plasma [22]. To gain further insight into the
molecular causes of the triglyceride accumulation in the
absence of macroH2A1, we investigated a possible cor-
relation between this phenotype and the expression level
of a few genes important for lipid metabolism that have
been previously shown to be regulated by macroH2A1
[23] (Figure 5).
The expression level of lipoprotein lipase (Lpl), which
catalyses the hydrolysis of the triacylglycerol component
of circulating chylomicrons and very low-density lipo-
proteins [24], was not affected by the mutation (Figure
5b). Mice lacking macroH2A1 presented an upregula-
tion of CD36 (Figure 5a), a fatty acid transporter in
muscle and adipose tissue. By contrast, Thrsp (thyroid
hormone responsive SPOT14 homolog), a regulator of
de novo lipogenesis, was downregulated in H2afy
-/- livers
compared with controls (Figure 5c) [25]. Thus, our
results suggest that Thrsp belongs to the recently dis-
covered category of genes that are positively regulated
by macroH2A1 [13].
No differences in Thrsp or CD36 expression were
observed between H2afy
-/- females showing a steatotic
liver and those with a healthy liver (Figure 5a, c). There-
fore, it is unlikely that the steatotic phenotype observed
in H2afy
-/- females was a consequence of the deregula-
tion of CD36 and Thrsp expression.
Remarkably, the X-linked Tbg gene (also named Ser-
pina7) was overexpressed by sixfold in H2afy
-/- female
Figure 2 MacroH2A1 is not required for DNA repair in vivo. Survival of 7-week-old H2afy
-/- mice and littermate controls exposed to 6.5 Gy
whole-body gamma irradiation. Four H2afy
-/- (black circles) and six control mice were used (open circles). H2afy-deficient mice were not
hypersensitive to DNA damage induced by ionizing irradiation, suggesting that macroH2A1 is not essential for DNA repair.
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Page 4 of 13mice with a steatotic phenotype compared with healthy
mutant or wild-type females, which both expressed Tbg
at the same level (Figure 5e). TBG is a thyroid hor-
mone-binding protein, which carries the majority of the
hormone T4 in the serum [26]. Given that thyroid hor-
mones influence general energy metabolism and
specifically promote increases in lipid metabolism and
counteract lipid accumulation [27], overexpression of
Tbg in H2afy
-/- females and its consequences on lipid
metabolism could be the origin of the hepatic steatosis
we observed.
To test if the overexpression of Tbg was a consequence
of a global reactivation of Xi in the absence of
macroH2A1, we examined expression of Dlg3,a n o t h e r
gene located on the X-chromosome (Figure 5d). Although
the expression level of Dlg3 was slightly elevated in mutant
mice, Dlg3 did not show any significant upregulation in
steatotic liver (Figure 5d). Together, these data indicate
that the inactive X-chromosome is not fully reactivated in
the absence of macroH2A1, indicating that macroH2A1 is
not required for global silencing of Xi.
Figure 3 H2afy deletion causes female-specific steatosis. Pathological analysis of the livers from (b, d) H2afy-targeted and (a, c) littermate
control mice stained with (a, b) hematoxylin and eosin and (c, d) oil-red O. (b) Microscopic examination of the livers revealed that H2afy
-/-
animals exhibited macrovesicular steatosis mainly in the periportal areas. Strikingly, hepatic steatosis was observed only in H2afy
-/- females. (d)
Hepatic steatosis was due to the accumulation of neutral fat in liver, as documented by the positive oil red O staining. The long arrow indicates
the portal tract and the short arrow the centrilobular vein.
Table 1 Hepatic steatosis incidence
Control
littermates
macroH2A1
-/-
Male Female Male Female
Mice presenting hepatic steatosis, n 0 0 0 9
Total examined mice, n 3 7 8 17
Incidence, % 0 0 0 53
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Page 5 of 13Figure 4 Steatosis is not linked with endogenous retrovirus reactivation. (a) Northern blot analysis of endogenous MLVenv expression in
liver. Hybridization with a Gapdh probe was used to show equal loading of the lanes. (b) Quantification of the intensity of the band from the
northern blot. The histogram indicates the relative difference (after normalization for Gapdh expression) in the abundance of MLVenv transcripts
with respect to levels observed in wild-type mice, which were set at 1. The error bars represent SEM.
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Page 6 of 13Figure 5 The steatosis incidence correlates with Tbg overexpression. Real-time quantitative expression analysis of key genes in liver: CD36,
Lpl and Thrsp code for proteins involved in fatty acid metabolism; Tbg and Dlg3 are X-linked genes. Tbg presented transcriptional upregulation
correlating with the incidence of hepatic steatosis. Gene expression was normalized to Gapdh levels. Expression levels were corrected against
expression measured in control littermate liver, which was defined as 1. The error bars represent SEM.
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Page 7 of 13MacroH2A1 occupies the female but not the male Tbg
promoter
To determine if macroH2A1 directly controls the
expression of genes most perturbed in H2afy
-/- liver, we
performed chromatin immunoprecipitation (ChIP)
experiments to test for the presence of macroH2A1 in
nucleosomes that occupied promoters of those genes in
livers of wild-type animals (Figure 6).
We first analysed chromatin extracted from female
livers (Figure 6a). We did not detect the presence of
macroH2A1 above the background level on the Lpl
gene, which was not deregulated in the absence of
macroH2A1 (Figure 5b). By contrast, wild-type female
hepatocytes displayed high levels of macroH2A1 incor-
porated into the sequence upstream of the Tbg tran-
scription start site (Figure 6a). This finding strongly
suggests that increased expression of Tbg measured in
H2afy
-/- livers is a direct consequence of H2afy
disruption.
To determine the molecular cause of the sexual
dimorphism of the steatosis promoted by H2afy disrup-
tion, we compared macroH2A1 levels on the Tbg pro-
moter in male versus female animals (Figure 6b).
Consistent with our first analysis (Figure 6a), we found
that macroH2A1 is 10-fold enriched on the Tbg promo-
ter in females (Figure 6b). Furthermore, our ChIP analy-
sis shows that in contrast to females, the Tbg promoter
in males has low amounts of bound macroH2A1 (Figure
6b). It should be mentioned that in a previous study
[23], this sex-specific difference was not noted. This
might be the result of differences in the purification
method of macroH2A containing nucleosomes (immu-
noprecipitation in this study; biochemical purification in
the previous study [23]). However, in the previous study,
Tbg expression was shown to be four times higher in
the livers of wild-type adult males than in wild-type
adult females [23]. Hence, the sexual dimorphic expres-
sion of Tbg i nw i l d - t y p em i c ei sp r o b a b l yc a u s e db yt h e
low incorporation of macroH2A1 on the Tbg promoter
in male hepatocytes.
We conclude that the sexual dimorphism of the phe-
notype caused by H2afy deletion is caused by the sex-
dependent incorporation of macroH2A1 at specific loci,
as evidenced by the sex-specific incorporation of
macroH2A1 on the Tbg promoter.
Discussion
Our study provides novel insights into macroH2A1
functions in X-chromosome inactivation and lipid meta-
bolism. Loss of function of H2afy causes hepatic accu-
mulation of lipid specifically in female mice.
Interestingly, a recent report has demonstrated that
mice fed with a methyl-deficient diet that induces hepa-
tic steatosis had an elevated level of macroH2A [28].
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Figure 6 MacroH2A1 is specifically incorporated into the
female Tbg promoter. Chromatin immunoprecipitation (ChIP)
analysis of the association of macroH2A1 with key gene promoters
involved in lipid metabolism. (a) ChIP analysis of macroH2A1
enrichment level on Tbg and Lpl promoters in females. The graph
shows that macroH2A1 was enriched at Tbg promoter but not at
the Lpl promoter in female hepatocytes. (b) The Tbg promoter in
male mice was not significantly occupied by macroH2A1. ChIP
using liver chromatin from wild-type (WT) animals and H2afy
-/-
knockout (KO) mice was performed using anti-macroH2A1 antibody.
Quantitative PCR was then performed with specific primers for
promoter regions of the Tbg and Lpl genes as indicated in Materials
and methods. The results are presented as the fold enrichment in
wild-type animals compared with Tbg promoter DNA amplified in
KO female mice. The graph represents the average of three
independent experiments.
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pose that the elevated level of macroH2A reported in
this study reflects a homeostatic response within the
liver that is ultimately saturated after prolonged expo-
sure to high levels of lipids. In the light of this study
[28], our findings indicate that macroH2A could be
incorporated at high levels in chromatin in order to cir-
cumscribe hepatic lipid accumulation.
Using a similar approach, Changolkar and colleagues
have independently shown that H2afy-deficient mice are
viable, and that the mutation does not result in any
obvious macroscopic phenotype [23]. Those indepen-
dent data consistently demonstrated that macroH2A1
does not play a fundamental role during development;
however, two recent studies have shown that
macroH2A1 is preferentially incorporated at develop-
mental gene promoters [13,21]. This apparent contradic-
tion might be explained by the potential existence of
redundant chromatin silencing pathways. One hypoth-
esis suggests functional compensation by the polycomb
repressive complex (PRC)2, as indicated by its colocali-
sation with macroH2A1 [29]. This hypothesis is also
sustained by the genome-wide colocalisation between
macroH2A1 and the trimethylation of lysine 27 of his-
tone H3, the histone posttranslational modification cata-
lysed by PRC2 [13,30]. However, the possible redundant
roles of PRC2 and macroH2A1 remain to be experimen-
tally tested.
In addition, the study of Changolkar et al. showed that
H2afy disruption has a minor influence on gene expres-
sion, as only seven genes displayed significant abnormal
expression in the absence of macroH2A1 [23]. The sur-
prisingly low number of genes affected by the
macroH2A1 deletion could be explained either by possi-
ble functional compensation by another redundant chro-
matin repressive mechanism or by the presence of
genetic modifiers, as discussed below. Very interestingly,
four genes deregulated in H2afy
-/- livers encode proteins
directly involved in fatty acid metabolism, which further
supports the role of macroH2A1 in lipid homeostasis
control as highlighted in our study. We have indepen-
dently confirmed the abnormal upregulation of three of
these genes in H2afy
-/- liver. However, we found a
decreased level of Thrsp in mutant female liver, whereas
the study of Changolkar et al. concluded that Thrsp
expression is not affected by H2afy disruption in female
hepatocytes [23].
The major discordance between these two parallel stu-
dies concerns liver steatosis; there is no mention of this
in the study from Changolkar et al. [23]. This important
difference could be explained by the different genetic
backgrounds of mice in these two studies. The study by
Changolkar et al. was performed using a fixed mutation
on the C57Bl6 background whereas the mutants we
analysed had a genetic background composed of half
129Ola and half C57Bl6 (intercrosses of the F2 genera-
tion). Such interference of the genetic background with
the phenotype has been extensively documented for
many genes [31]. Likewise, variation of the genetic back-
ground has been reported to have significant influences
on both the quantities of macroH2A1 in steatotic liver
and the incidence of steatosis [28].
Additionally, our data reveal that the penetrance of
the steatotic phenotype of female progenies of C57Bl/
6 × 129Ola mice was very close to half. This consistent
penetrance in half the animals over several intercross
generations indicates the existence of a genetic modifier
present in one of the two mixed genetic backgrounds
that is able to modify the penetrance of the phenotype
resulting from H2afy deletion. Identification of this
genetic modifier should expand our knowledge of the
metabolic pathway controlled by macroH2A1 in female.
Our study uncovers part of the molecular mechanism
by which macroH2A1 regulates lipid homeostasis.
Indeed, we show that macroH2A1 silences Tbg expres-
sion in female liver, as evidenced by the overexpression
of Tbg in the absence of macroH2A1. We also provide
evidence of specific enrichment of macroH2A1 on the
Tbg promoter, which indicates that macroH2A1 directly
regulates Tbg transcription.
The consequences of Tbg overexpression in mice are
unknown. However, studies in patients with amplifica-
tion of the Tbg gene revealed that excess TBG can lead
to hypothyroidism and altered metabolism [32,33].
Thus, we propose that elevated levels of TBG, the main
T4 hormone carrier, could be the cause of the alteration
in lipid metabolism responsible for hepatic steatosis in
the absence of macroH2A1.
The reactivation of the X-linked Tbg caused by H2afy
disruption raises the possibility that the remarkable sex-
ual dimorphism of the phenotype might be due to Xi
silencing failure in the absence of macroH2A1. How-
ever, we found that expression of Dlg3, another X-linked
gene, is not affected by H2afy disruption. Therefore, Xi
is not entirely reactivated in the absence of macroH2A1.
In good agreement with our conclusion, a global analy-
sis of gene expression in H2afy
-/- liver did not report
evidence of Xi reactivation in the absence of
macroH2A1 [23]. This notion was reinforced by a pre-
vious study, which reported that H2afy knockdown is
not sufficient to reactivate the transcription of a reporter
gene stably inserted in Xi [34].
Given the low level of macroH2A1 incorporated into
the male Tbg promoter, we propose that the sexual
dimorphism of the phenotype could be due to the selec-
tive incorporation of macroH2A1 on the Tbg promoter
in female cells. Our measurements show that the
amount of macroH2A1 incorporated into the Tbg
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Page 9 of 13promoter is about fivefold higher in female mice than in
male mice. This 5:1 ratio cannot be explained by the
twofold difference of the X-chromosome copy number
between the sexes. Instead, the difference in macroH2A1
occupancy at the same locus between males and females
is probably caused by an unbalanced incorporation of
macroH2A1 between the sexes. Specific enrichment on
the female X-linked Tbg promoter could possibly be a
reflection of the specific incorporation of macroH2A1
on Xi [2-4,35]. The different levels of macroH2A1 on
the Tbg promoter locus between the sexes might also be
a consequence of a more general differential genomic
localisation of histone variants between different cell
types (for example, male versus female).
Conclusions
Although much effort has been devoted to understand-
ing the role of macroH2A1 in gene silencing, its biologi-
cal function remains elusive. Recent advances that
uncovered its association with PARP-1 have led to the
speculation that macroH2A1 could be involved in DNA
r e p a i r .H o w e v e r ,w er e p o r th e r et h a tH2afy
-/- mutants
are not hypersensitive to DNA DSB, excluding a funda-
mental role of macroH2A1 in the control of the DNA
damage response.
In addition, we have shown that loss of function of
H2afy causes hepatic accumulation of lipid specifically
in females. We also report a correlation between
macroH2A1 occupancy on the Tbg promoter and its
specific overexpression in steatotic liver, which strongly
supports our hypothesis that Tbg deregulation is the
major cause of lipid metabolism dysfunction in the
absence of macroH2A1. Thus, our study provides novel
insights into macroH2A1 functions in X-linked gene
silencing and lipid metabolism.
The importance of chromatin in the control of home-
ostasis has recently begun to be uncovered with the dis-
covery of the role of histone deacetylase and histone
demethylase in the regulation of energy metabolism
[36,37]. Our work highlights that histone variants are
also involved in the regulation of lipid metabolism.
Methods
All experiments on mice were carried out with CREA
Rhône-Alpes (France) committee approval. Mice were
normally housed in cages with littermates of the same
sex. Animals were kept in a 12-hour light/dark cycle
and fed standard diet rodent chow (SAFE #A04-10 and
SAFE #A03-10 for breeders; Perotech Sciences Inc., Tor-
onto, ON, Canada).
Generation of macroH2A1 targeted mice
H2afy was disrupted by replacing exon 2 with a neomy-
cin resistance cassette. Both recombination fragments
were first amplified using DNA polymerase (Phusion;
New England BioLabs, Ipswich, MA, USA) and appropri-
ate primers (Table 2) on DNA extracted from E14.1 ES
cells, then cloned into SalIa n dXhoI restriction sites,
respectively, of the pLN-TK targeting vector (Figure 1).
The resulting vector was linearized with MluI and elec-
troporated into E14.1 ES cells (129/Ola strain) as
described previoulsy [38]. After antibiotic selection
(G418/Geneticin; Gibco-BRL, Grand Island, NY, USA),
homologous recombinants were identified by PCR using
the set of primers named ‘screen2 F’ and ‘NeoLOXP2 R’
shown in Table 2. Homologous recombination was con-
firmed by Southern blotting and extensive restriction
analysis, using flanking and internal probes (data not
shown). Two different ES clones heterozygous for the
targeted mutation were injected into C57Bl/6 blastocysts
and transferred into pseudopregnant foster mothers. One
clone gave high-level chimeras and transmitted the dis-
rupted H2afy allele to offspring at high frequency when
crossed into C57Bl/6 mice. The mice were maintained by
intercrosses of the original 129Ola × C57Bl/6 mice. The
animals were genotyped by PCR on genomic DNA
Table 2 List of primers
Primer name 5’ ! 3’
Forward Reverse
5’’ recombination arm AGCTCGAGCTAGAATGGTGAACAGGTTGGAAGG TTGTCGACAAACAGATCAGCGAGCTCACTGC
3’ recombination arm AGCTCGAGCTGGTCTGCACACATCCTTTAAGG ACAGGAGTCAAGATGGTGGCTGGG
Dlg3* CTATGGGACCAGCATCCAGT TGTGCTTGCTGCAGTCTCTT
Tbg* AAGGCTGTGCTACACATTGG CGGATAACAGGGTGAAGAGG
Lpl* GAGCGAGAACATTCCCTTCA TCTGAGTCTCTCCGGCTTTC
CD36* GCAAAGTTGCCATAATTGAGTCC GTCTGTGCCATTAATCATGTCG
Thrsp* GAGTGCATCTGTGGACTTGG GAGTAACTGCGACATGACACC
GAPDH* CAACTACATGGTCTACATGTTC CGCCAGTAGACTCCACGAC
18S* CGGCTACCACATCCAAGGAA GCTGGAATTACCGCGGCT
*Reverse transcriptase PCR.
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F’ located in intron 1-2 and ‘screen R’ located in the
targeted portion of intron 2-3, and a third primer com-
plementary to the neo gene ‘NeoLOXP2 R’ (Table 2).
This resulted in the amplification of a 500 bp fragment
from the wild-type macroH2A1 allele and a 310 bp frag-
ment from the null allele.
Immunoblotting
Nuclear proteins were isolated from tissues in accor-
dance with the protocol described previously [39].
Briefly, 10 μg of nuclear proteins were separated by
SDS-PAGE and transferred onto nitrocellulose mem-
branes. For the detection of macroH2A1, a polyclonal
antibody (Millipore Inc., Billericay, MA, USA) was used.
MacroH2A2 was detected using a rabbit polyclonal anti-
body (cat. no. ab4173; Abcam Inc., Cambridge, MA,
USA) at a dilution of 1:2000. Histone H2B was detected
using a rabbit polyclonal antibody (cat. no. 07-371;
Millipore) at a dilution of 1:5000 [39].
Southern blotting
For Southern blotting, 10 μg of DNA were digested with
100 U of EcoRI, then separated by agarose gel electro-
phoresis and transferred onto a nitrocellulose mem-
brane, followed by UV crosslinking. Filters were
hybridized with a
32P-labelled probe located 5’ to the
sequences in the targeting vector (Figure 1). Membranes
were washed at 65°C, twice with 1× saline sodium
citrate (SSC) buffer plus 0.1% SDS for 15 minutes each,
and twice with 0.1× SSC plus 1% SDS for 30 minutes
each, then exposed to a phosphor screen for 24-72
hours. The gel images were acquired with a scanner
(Fujifilm 217 FLA-5100; Fujifilm Holdings Corp., Tokyo,
Japan) and the pictures were analyzed with Multigauge
V.3.0 software (Fujifilm).
Survival of mice after whole body gamma irradiation
For induction of DNA damage, 7-8-week-old H2afy
-/-
mice and control littermates were exposed to whole-
body sublethal ionizing irradiation. Animals were irra-
diated with a
137Cs source at a rate of 0.68 Gy/min in
single doses of 6.5 Gy. H2afy-deficient mice and seven
control littermates were irradiated, and survival was
determined. Four days after irradiation, one mutant and
o n ew i l dt y p ew e r ek i l l e df o rhistopathological analysis
of the small intestine.
Histological analysis
Formaldehyde-fixed, paraffin wax-embedded sections
were prepared from liver samples, and were stained with
hematoxylin and eosin using standard methods. Frozen
liver sections were stained with oil red O. Sections were
photographed at 20× magnification.
Total RNA preparation, reverse transcription and
quantitative PCR
Total RNA was isolated using TRIzol reagent (Invitro-
gen Corp., Carlsbad, CA, USA) and treated with DNaseI,
then 5 μg of RNA were reverse transcribed (RevertAid
Reverse Transcriptase; Fermentas, Burlington, ON,
Canada). Quantitative reverse transcriptase (RT) PCR
reactions were performed using the Light-Cycler system
(Roche Applied Science; Indianapolis, IN, USA) to
determine mRNA levels of Tbg, Lpl, CD36, Thrsp and
Dlg3 (specific primers are listed in Table 2). All cDNAs
were normalized using primers to Gapdh.E x p r e s s i o n
levels were corrected against expression measured in
control littermate liver, which was defined as 1. cDNA
levels from wild-type (n = 2), steatotic macroH2A1
-/-
(n = 4) and healthy macroH2A1
-/- (n = 3) were com-
pared, and results expressed as mean ± SEM.
Northern blotting
For Northern blotting, 10 μg of total RNA were dena-
tured and subjected to electrophoresis in a 1% agarose
plus 1.9% formaldehyde gel in 1× MOPS buffer, and
transferred to a nitrocellulose membrane. The mem-
brane was hybridized with probes derived from radiola-
beled extension of random hexamers annealed to the
purified 1011 bp fragments produced by MelARVenv
digestion by NcoI (described in [40]) or Gapdh pre-
viously amplified from cDNA using the primers listed in
Table 2. Quantification of the intensity of the bands was
performed using MultiGauge V.3.0 software (Fujifilm).
Gapdh mRNA served as an internal control, and expres-
sion levels of MLV were set to 1 for the wild-type litter-
mate controls. Results are expressed as mean ± SEM.
Chromatin immunoprecipitation
Mouse liver tissue (1 g) was homogenized in buffer H
(250 mM sucrose, 3 mM CaCl2 in 20 mM Tris pH 7.4) in
the presence of a cocktail of protease inhibitors cocktail
(Roche Applied Science, Basel, Switzerland) and spun in
a centrifuge at 280 g, for 10 min at 4°C (A-4-81 rotor;
Eppendorf North America, Westbury, NY, USA). The
resulting pellet was collected and washed three times in
phosphate-buffered saline (PBS) and carefully resus-
pended in a 2.4 M sucrose cushion (2.4 M sucrose, 1 mM
MgCl2, 10 mM Tris pH 6.8 and protease inhibitor cock-
tail). The suspension was centrifuged at 168,000 g for 3
hours at 4°C (SW41 Ti rotor; Beckmann-Coulter Inc.,
Brea, CA, USA). The nuclear fraction was carefully
collected and washed three times in PBS plus protease
inhibitor cocktail, then counted and divided into aliquots.
Following this, 1.5 × 10
6 nuclei were crosslinked for 10
min in 1% paraformaldehyde at room temperature and
sheared by sonication to produce DNA fragments aver-
aging 500 bp in length. The sheared chromatins were
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Page 11 of 13immunoprecipitated with anti-macroH2A1 antibody (cat.
no. 07-219; Upstate Biotech). Precipitated DNA and pro-
tein complexes were uncrosslinked and purified by phe-
nol/choloroform extraction. Purified DNA was used as
templates for qPCR quantification using Tbg or Lpl speci-
fic primers listed in Table 2.
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